Literature DB >> 11520191

Ethical considerations in neonatal resuscitation: clinical and research issues.

R J Boyle1, N McIntosh.   

Abstract

The recent publication of guidelines for ethical decision making for resuscitation of infants has highlighted the problems inherent in using the currently available data to define those situations in which resuscitation should be or might be withheld or withdrawn. Prior selection criteria for resuscitation, criteria for inclusion into the study group, incomplete resuscitation, gestational age determination, intrauterine growth restriction, subjective assessment of 'poor' outcome, and other factors make setting specific parameters for acting or not acting difficult, if not dangerous, and possibly impossible. Research in neonatal resuscitation poses some potential ethical obstacles, but national and international regulations and guidelines are available to assist investigators in study design. Copyright 2001 Harcourt Publishers Ltd.

Entities:  

Mesh:

Year:  2001        PMID: 11520191     DOI: 10.1053/siny.2001.0054

Source DB:  PubMed          Journal:  Semin Neonatol        ISSN: 1084-2756


  3 in total

1.  Stillbirths and live births in the periviable period.

Authors:  Holly Elser; Alison Gemmill; Joan A Casey; Deborah Karasek; Tim Bruckner; Jonathan A Mayo; Henry C Lee; David K Stevenson; Gary M Shaw; Ralph Catalano
Journal:  Ann Epidemiol       Date:  2020-07-08       Impact factor: 3.797

2.  The acceptability among lay persons and health professionals of actively ending the lives of damaged newborns.

Authors:  Nathalie Teisseyre; Charles Vanraet; Paul C Sorum; Etienne Mullet
Journal:  Monash Bioeth Rev       Date:  2010-09

Review 3.  The ethical issues regarding consent to clinical trials with pre-term or sick neonates: a systematic review (framework synthesis) of the analytical (theoretical/philosophical) research.

Authors:  Christopher Megone; Eleanor Wilman; Sandy Oliver; Lelia Duley; Gill Gyte; Judy Wright
Journal:  Trials       Date:  2016-09-09       Impact factor: 2.279

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.